Published on Apr 20, 2012 by SaluteDomaniTV
Chronic hepatitis c is a viral infection of the liver that affects approximately 130 to 1170 million people around the world.
If left untrated, Hcv infection is potentially serious disease that can damage the liver over time and lead cirrhosis, end stage liver disease and liver cancer.
Victrelis -boceprevir is approved for treatment of Hcv genotype 1 infection, in combination with peginterferon alfa and ribavirin in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
No comments:
Post a Comment